Effective dose of 5-fluorouracil for myringotomy in rats

被引:0
|
作者
Cincik, H
Güngör, A
Saglam, M
Çekin, E
Yildirim, S
Poyrazoglu, E
机构
[1] Gulhane Mil Med Acad, Haydarpasa Training Hosp, Dept ENT, Istanbul, Turkey
[2] Gulhane Mil Med Acad, Haydarpasa Training Hosp, Dept Pathol, Istanbul, Turkey
来源
MEDICAL SCIENCE MONITOR | 2005年 / 11卷 / 09期
关键词
myringotomy; 5-fluorouracil; middle ear; ventilation;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The purpose of this study is to compare the effects of two different doses of 5-fluorouracil (5-FU) on closure rates and histopathological findings in myringotomy to those of simple myringotomy with saline application. Material/Methods: 36 rats were divided into two study groups and a control group of 12 rats each. After bilateral myringotomy, we applied 5-FU 50 mg/ml in group A, 10 mg/ml in group B and saline in the control group for 10 minutes. Examination was made by otoendoscopy on days 1, 3, 5, 7, 10, 15, 20, 25. After the follow tip examination, two rats from each group were randomly sacrificed on days 7, 15, 25 and 35. Both tympanic membranes were investigated for fibrosis and inflammation by light microscopy. Results: Most of the tympanic membranes from group B and the control group healed on the 10(th) day, but 16 myringotomies were patent in group A; by the 25(th) day, all myringotomies in all three groups were completely healed. The mean healing time was 14.62 days, 10.20 days and 10.40 days respectively in groups A, B and control. Fibrosis and inflammation were less in group A than in group B and the controls. Conclusions: 5-FU at a concentration of 50 mg/mL is effective in prolonging the patency of myringotomies in rat tympanic membranes, while a concentration of 10 mg/mL has no greater effect than a simple myringotomy procedure with saline application.
引用
收藏
页码:BR330 / BR334
页数:5
相关论文
共 50 条
  • [41] Concurrent chemoradiotherapy in esophageal cancer; Comparison between intermittent high dose cisplatin with 5-fluorouracil and daily low dose cisplatin with continuous low dose infusion of 5-fluorouracil
    Sal, H
    Mitsumori, M
    Araki, N
    Okumura, S
    Nishimura, Y
    Hiraoka, M
    RADIOLOGY, 2002, 225 : 415 - 415
  • [42] 5-FLUOROURACIL AND DERIVATIVES IN CANCER CHEMOTHERAPY - DETERMINATION OF 5-FLUOROURACIL IN BLOOD
    WINDHEUS.JJ
    SUTTER, JL
    AUEN, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (02) : 301 - &
  • [43] Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil
    Patel, M
    Ardalan, K
    Hochman, I
    Tian, EM
    Ardalan, B
    ANTICANCER RESEARCH, 2003, 23 (1A) : 447 - 452
  • [44] DOSE-INTENSE 5-FLUOROURACIL IN COLORECTAL-CANCER
    CODACCIPISANELLI, G
    SEMINARA, P
    GARGANO, L
    RENZI, AR
    ARONNE, T
    FRANCHI, F
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (02) : 61 - 64
  • [45] A SAFE AND EFFECTIVE METHOD OF ADMINISTERING 5-FLUOROURACIL TO ADRENALECTOMIZED PATIENTS
    HALL, TC
    WILSON, RE
    SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY, 1966, 123 (05): : 978 - +
  • [47] SYNTHESIS OF 5-FLUOROURACIL DERIVATIVES CONTAINING AN INHIBITOR OF 5-FLUOROURACIL DEGRADATION
    HIROHASHI, M
    KIDO, M
    YAMAMOTO, Y
    KOJIMA, Y
    JITSUKAWA, K
    FUJII, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1993, 41 (09) : 1498 - 1506
  • [48] PHARMACOKINETIC STUDIES OF 5-FLUOROURACIL AND 5'-DEOXY-5-FLUOROURIDINE IN RATS
    AU, JLS
    WALKER, JS
    RUSTUM, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1983, 227 (01): : 174 - 180
  • [49] Hepatic extraction ratio of 5-fluorouracil in rats - Dose dependence and effect of uracil and interleukin-2
    Fuse, E
    Takai, K
    Okuno, K
    Kobayashi, S
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (04) : 561 - 568
  • [50] Trabeculectomy with 5-fluorouracil
    Stavrou, P
    Corridan, PGJ
    SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 533 - 537